Abstract
Background
Studies of cognition after LVAD surgery have produced mixed results. To explore whether cognition would improve, decline, or remain stable after LVAD surgery, we examined cognition before and 1- and 3-months after LVAD surgery. Patients with post-surgical stroke were excluded.
Methods
28 subjects (mean age = 54.31 ± 12 years) comprised an observational case series from the DuraHeart LVAS device® trial. Cognitive testing was performed at baseline, 1-month, and 3-month post-surgery, and included tests of attention, memory, language, visualmotor speed (TMT) and visualconstruction.
Results
No difference in cognition was found between baseline and 1-month exams (means z score improvement = 0.06, p = 0.43) but cognition improved significantly between baseline and 3-month exams (mean z score improvement = 0.34, p < 0.00001). Examination of individual test scores found, after correction for multiple comparisons, only the TMT variable was significantly different at the 3-month exam.
Conclusions
We found significantly improved cognition 3 months after LVAD surgery in a subset of patients without post-surgical stroke. The reasons for the lack of cognitive improvement at the 1-month post-surgical assessment may include ongoing medical and physiological disruptions in the immediate post-operative period. Further research into the sources of delayed improvement is warranted. Cognitive assessments performed immediately after surgery should be interpreted with caution because the results may not reflect longer term cognitive outcomes. LVAD patients may require additional support to successfully manage their health in the weeks immediately following surgery but assistance needs may decrease over time.
Similar content being viewed by others
References
Kadakia S, et al. Current status of the implantable LVAD. Gen Thorac Cardiovasc Surg. 2016;64(9):501–8.
Kato N, Jaarsma T, Ben T, Gal. Learning self-care after left ventricular assist device implantation. Curr Heart Fail Rep. 2014;11:290–8.
Butts B, Gary R. Coexisting frailty, cognitive impairment, and heart failure: implications for clinical care. J Clin Outcomes Manag. 2015;22(1):38–46.
Festa JR, et al. Association of low ejection fraction with impaired verbal memory in older patients with heart failure. Arch Neurol. 2011;68(8):1021–6.
Hajduk AM, et al. Cognitive impairment and self-care in heart failure. Clin Epidemiol. 2013;5:407–16.
Petrucci RJ, et al. Neurocognitive assessments in advanced heart failure patients receiving continuous-flow left ventricular assist devices. J Heart Lung Transpl. 2009;28(6):542–9.
Petrucci RJ, et al. Neurocognitive function in destination therapy patients receiving continuous-flow vs pulsatile-flow left ventricular assist device support. J Heart Lung Transpl. 2012;31(1):27–36.
Slaughter MS, et al. Low incidence of neurologic events during long-term support with the HeartMate XVER left ventricular assist device. Tex Heart Inst J. 2008;35(3):245–9.
Komoda T, et al. Executive cognitive dysfunction without stroke after long-term mechanical circulatory support. Am Soc Artif Intern Organs J. 2005;51:764–8.
Mapelli D, et al. Clinical psychological and neuropsychological issues with left ventricular assist devices (LVADs). Ann Cardiothorac Surg. 2014;3(5):480–9.
Fendler TJ, et al. Incidence and predictors of cognitive decline in patients with left ventricular assist devices. Circ Cardiovasc Qual Outcomes. 2015;8:285–91.
Bhat G, Yost G, Mahoney E. Cognitive function and left ventricular assist device implantation. J Heart Lung Transpl. 2015;34(11):1398–405.
Morgan JA, et al. Stroke while on long-term left ventricular assist device support: incidence, outcome, and predictors. Am Soc Artif Intern Organs J. 2014;60(3):284–9.
Moazami N, et al. Lessons learned from the first fully magnetically levitated centrifugual LVAD trial in the United States: the Duraheart Trial. Ann Thorac Surg. 2014;98:541–8.
Frontera JA et al. Risk factors, mortality, and timing of ischemic and hemorrhagic stroke with left ventricular assist devices. J Heart Lung Transpl. 2016; 36(6):673–83.
Rouleau I, et al. Quantitative and qualitative analyses of clock drawings in Alzheimer’s and Huntington’s disease. Brain Cogn. 1992;18(1):70–87.
Corporation TP. Wechsler adult intelligence scale-III. 3rd ed. San Antonio: Corporation TP; 1997.
Brandt J, Benedict RH. Hopkins verbal learning test-revised. Odessa: PAR; 2001.
Reitan RM, Wolfson D. The Halstead-Reitan Neuropsychological test battery. 2nd ed. S. Tucson: Neuropsychology Press; 1993.
Calamia M, Markon K, Tranel D. Scoring higher the second time around: meta-analyses of practice effects in neuropsychological assessment. Clin Neuropsychol. 2012;26(4):543–70.
Mark VW. Stroke and behavior. Neurol Clin. 2016;34:205–34.
Bauer LC, Johnson JK, Pozehl BJ. Cognition in heart failure: an overview of the concepts and their measures. J Am Acad Nurse Pract. 2011;23:577–85.
Bennett MK, Adatya S. Blood pressure management in mechanical circulatory support. J Thorac Dis. 2015;12:2125–8.
Harkness K et al. Screening for cognitive deficits using the Montreal Cognitive Assessment tool in outpatients ≥ 65 years of age with heart failure. Am J Cardiol. 2011;107:1203–7.
Khan T, et al. Delayed reversal of impaired metabolic vasodilation in patients with end-stage heart failure during long-term circulatory support with a left ventricular assist device. J Heart Lung Transpl. 2007;16(4):449–53.
Lietz K et al. The role of cerebral hyperperfusion in postoperative neurologic dysfunction after left ventricular assist device implantation for end-stage heart failure. J Thorac Cardiovasc Surg. 2009;137(4):p. 1012–9.
Boyle AJ et al. Cerebral hyperperfusion syndrome following LVAD implantation. J Heart Lung Transpl. 2003;22(1):S203.
Sansone R et al. Macrovascular and microvascular function after implantation of left ventricular assist devices in end-stage heart failure: role of microparticles. J Heart Lung Transpl. 2015;34:921–32.
Lavi S et al. Impaired CO2 vasoreactivity; association with endothelial dysfunction. Am J Physiol Heart Circ Physiol. 2006;291:H1856–H1861.
Bellapart J, et al. The effect of ventricular assist devices on cerebral autoregulation: a preliminary study. BMC Anesthesiol. 2011;11:4. https://doi.org/10.1186/1471-2253-11-4.
Ono M, et al. Cerebral blood flow autoregulation is preserved after continuous-flow left ventricular assist device implantation. J Cardiothorac Vasc Anesth. 2012;26(6):p. 1022–8.
Cornwell WKI, et al. Effect of pulsatile and nonpulsatile flow on cerebral perfusion in patients with left ventricular assist devices. J Heart Lung Transpl. 2014;33:p. 1295–303.
Acknowledgements
Partial support for this work was provided by Terumo Medical Inc. The authors would like to thank Databean, LLC for assistance in data collection. The authors would like to thank Jimmy K. Duong, MPH (Mailman School of Public Health, Columbia University) for assistance with statistical analyses.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest and funding sources
Author M. Pavol received support from Terumo Medical, Inc. for selection of the cognitive tests and collection and scoring of cognitive data for the Duraheart LVAS® study. No payment was received for manuscript preparation. Authors P. Marascalco and J. Harwood are employees of Terumo Heart, Inc. and assisted with collection, interpretation, and design of tables for adverse outcomes.
Rights and permissions
About this article
Cite this article
Pavol, M.A., Willey, J.Z., Wei, Y. et al. Does cognition improve following LVAD implantation?. Gen Thorac Cardiovasc Surg 66, 456–463 (2018). https://doi.org/10.1007/s11748-018-0947-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11748-018-0947-5